BREAKING
Acacia Research (ACTG) Q4 Adjusted EPS Surges 122.5% YoY to $0.03, Revenue Reaches $50.1M 13 minutes ago Acacia Research Corp (ACTG) Reports Q4 Earnings 14 minutes ago Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings 19 minutes ago Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings 27 minutes ago BridgeBio (BBIO) Reports Wider Q4 Loss of $1/Share vs $0.63 Estimate; Stock Surges 13% 28 minutes ago Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025 35 minutes ago ADC Therapeutics SA (ADCT) Reports Wider Loss Q4 EPS Estimates by 85.1% 53 minutes ago Priority Technology Holdings, Inc (PRTH) Reports Q4 Results 54 minutes ago Custom Truck One Source Inc (CTOS) Beats Q4 EPS Estimates 58 minutes ago Arq Inc (ARQ) Narrows Loss Q4 EPS Estimates by 111.1% 1 hour ago Acacia Research (ACTG) Q4 Adjusted EPS Surges 122.5% YoY to $0.03, Revenue Reaches $50.1M 13 minutes ago Acacia Research Corp (ACTG) Reports Q4 Earnings 14 minutes ago Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings 19 minutes ago Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings 27 minutes ago BridgeBio (BBIO) Reports Wider Q4 Loss of $1/Share vs $0.63 Estimate; Stock Surges 13% 28 minutes ago Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025 35 minutes ago ADC Therapeutics SA (ADCT) Reports Wider Loss Q4 EPS Estimates by 85.1% 53 minutes ago Priority Technology Holdings, Inc (PRTH) Reports Q4 Results 54 minutes ago Custom Truck One Source Inc (CTOS) Beats Q4 EPS Estimates 58 minutes ago Arq Inc (ARQ) Narrows Loss Q4 EPS Estimates by 111.1% 1 hour ago
ADVERTISEMENT
SPRO

Spero Therapeutics, inc

$SPRO NASDAQ Mar 11, 2021 AMC Q4 2020

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

SPRO Coverage

Event Spero Therapeutics (SPRO) Spero Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021 Nov 8, 2021 Event Spero Therapeutics, inc (SPRO) Spero’s Second Quarter 2021 Financial Results Conference Call Aug 9, 2021